European Medicines Agency considers Chinese vaccine


0
1 share
European Medicines Agency considers Chinese vaccine

The Covid-19 pandemic is almost over. On the one hand, vaccination efforts are underway, while countries are taking steps towards normalization. Vaccination, however, has sparked new controversy over safety.

Currently, there are three vaccines in our country: Sputnik V, Sinovac, and BioNTech. The vaccine at the center of the controversy is Sinovac, which is the most widely used vaccine in our country and comes from China. According to the latest information, the discussions are about to end.

European Medicines Agency begins testing of Chinese vaccine Sinovac

The EMA said in a statement that the decision to begin preliminary evaluation of the “Inactive Covid-19 Vaccine (Vero Cell)” was based on initial results from laboratory and clinical trials. Initial results showed that the vaccine produced antibodies to the virus that causes Covid-19.

European Medicines Agency considers Chinese vaccine 1

The agency will update the information as new details emerge about the Chinese vaccine and will investigate whether the vaccine is sufficient for European Union standards. The review will continue until sufficient evidence is obtained. If Sinovac fails this process, an official application can be made for approval of use in the EU.

EMA officials did not say how long the assessment would take. However, the agency keeps the process much shorter than normal due to the urgency of vaccination efforts.

See also  It was claimed that China "produced the coronavirus in the laboratory and tried to hide its traces"!

Like it? Share with your friends!

0
1 share

What's Your Reaction?

hate hate
0
hate
confused confused
0
confused
fail fail
0
fail
fun fun
0
fun
geeky geeky
0
geeky
love love
0
love
lol lol
0
lol
omg omg
0
omg
win win
0
win
Becks

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x